These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8398668)

  • 21. Barriers to antibiotic lock therapy in children with intravascular catheter-related bloodstream infections.
    Robinson JL; Tawfik G; Roth A
    Pediatr Infect Dis J; 2005 Oct; 24(10):944. PubMed ID: 16220107
    [No Abstract]   [Full Text] [Related]  

  • 22. Is systemic heparin a risk factor for catheter-related sepsis in dialysis patients? An evaluation of various biofilm and traditional risk factors.
    Diskin CJ; Stokes TJ; Dansby LM; Radcliff L; Carter TB
    Nephron Clin Pract; 2007; 107(4):c128-32. PubMed ID: 17957123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term management of the tunneled venous catheter.
    Liangos O; Gul A; Madias NE; Jaber BL
    Semin Dial; 2006; 19(2):158-64. PubMed ID: 16551295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prophylactic antibiotics for preventing early Gram-positive central venous catheter infections in oncology patients, a Cochrane systematic review.
    van de Wetering MD; van Woensel JB; Kremer LC; Caron HN
    Cancer Treat Rev; 2005 May; 31(3):186-96. PubMed ID: 15944048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of heparinized catheter lock solutions on systemic anticoagulation in hemodialysis patients.
    Thomson PC; Morris ST; Mactier RA
    Clin Nephrol; 2011 Mar; 75(3):212-7. PubMed ID: 21329631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Management of central venous catheter: prevention of thrombosis and bacteremia].
    Lomonte C; Basile C
    G Ital Nefrol; 2009; 26(1):73-80. PubMed ID: 19255966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arcanobacterium pyogenes bacteremia in a man on hemodialysis with central venous catheter.
    Chen XH; Liu Z; Shen B; Zou J
    J Vasc Access; 2015 Nov; 16(6):e103-4. PubMed ID: 26109538
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prevention of bacteremia from central venous catheters in hemodialysis: value of application of a mixture of rifampicin and protamine at the insertion site].
    Montagnac R; Schillinger F; Eloy C
    Nephrologie; 2003; 24(4):159-65. PubMed ID: 12891830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of central venous catheter-related coagulase-negative staphylococcal sepsis in neonates.
    Spafford PS; Sinkin RA; Cox C; Reubens L; Powell KR
    J Pediatr; 1994 Aug; 125(2):259-63. PubMed ID: 8040776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of sodium hypochlorite in the prevention of catheter related infections.
    Cruz DN; Ocampo C; Brendolan A; Menara G; Corradi V; de Cal M; Polanco N; Kuang D; Nalesso F; Crepaldi C; Ronco C
    Contrib Nephrol; 2007; 154():97-102. PubMed ID: 17099304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minocycline and ethylenediaminetetraacetate for the prevention of recurrent vascular catheter infections.
    Raad I; Buzaid A; Rhyne J; Hachem R; Darouiche R; Safar H; Albitar M; Sherertz RJ
    Clin Infect Dis; 1997 Jul; 25(1):149-51. PubMed ID: 9243049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of vancomycin-containing lock or flush solutions for prevention of bloodstream infection associated with central venous access devices: a meta-analysis of prospective, randomized trials.
    Safdar N; Maki DG
    Clin Infect Dis; 2006 Aug; 43(4):474-84. PubMed ID: 16838237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Panhemispheric infarction: a complication of cuffed catheter.
    Agraharkar M; Gokhale S; Cinclair R; Patel J; Gupta R
    South Med J; 2003 Feb; 96(2):194-7. PubMed ID: 12630647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sodium citrate 4% versus heparin as a lock solution in hemodialysis patients with central venous catheters.
    Yon CK; Low CL
    Am J Health Syst Pharm; 2013 Jan; 70(2):131-6. PubMed ID: 23292266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Life-threatening sepsis caused by Burkholderia cepacia from contaminated intravenous flush solutions prepared by a compounding pharmacy in another state.
    Held MR; Begier EM; Beardsley DS; Browne FA; Martinello RA; Baltimore RS; McDonald LC; Jensen B; Hadler JL; Dembry LM
    Pediatrics; 2006 Jul; 118(1):e212-5. PubMed ID: 16785290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Catheters: traveling the bacterial highway.
    Banerjee S
    Nephrol News Issues; 2008 Oct; 22(11):39, 46. PubMed ID: 19048694
    [No Abstract]   [Full Text] [Related]  

  • 37. Pros and cons of catheter lock solutions.
    Niyyar VD; Lok CE
    Curr Opin Nephrol Hypertens; 2013 Nov; 22(6):669-74. PubMed ID: 24100219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical alternatives to central venous catheters in chronic renal replacement therapy.
    Mickley V
    Nephrol Dial Transplant; 2003 Jun; 18(6):1045-51. PubMed ID: 12748332
    [No Abstract]   [Full Text] [Related]  

  • 39. Is blood culture a reliable guide to diagnosing catheter-related bacteremia (CRB)? A case of CRB caused by fungi and seven types of bacteria in a hemodialysis patient.
    Wang Z; Yang J; Tang X; Pi X; Li L; Yu J
    Int Urol Nephrol; 2014 Dec; 46(12):2421-2. PubMed ID: 24948200
    [No Abstract]   [Full Text] [Related]  

  • 40. A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis.
    Solomon LR; Cheesbrough JS; Ebah L; Al-Sayed T; Heap M; Millband N; Waterhouse D; Mitra S; Curry A; Saxena R; Bhat R; Schulz M; Diggle P
    Am J Kidney Dis; 2010 Jun; 55(6):1060-8. PubMed ID: 20207458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.